medigraphic.com
SPANISH

Medicina Crítica

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • Policies
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 2

<< Back Next >>

Med Crit 2025; 39 (2)

Pulmonary embolism disease identification at nuclear medicine in SARS-CoV-2 patients

Giraldo SJM, Giraldo SJM, Duque C, Andrade S, Uribe E
Full text How to cite this article 10.35366/121720

DOI

DOI: 10.35366/121720
URL: https://dx.doi.org/10.35366/121720

Language: Spanish
References: 9
Page: 106-110
PDF size: 2366.50 Kb.


Key words:

lymphopenia, Hageman, thrombin, dimer D, histones.

ABSTRACT

Lung devastating consequences in patients with new coronavirus infection are immersed by severe haematological and inflammatory disorders that joined with specific risk factors, exponentially increase mortality. Patients' subgroup was documented with embolic pulmonary disease with vascular distribution segmental defects by nuclear medicine whose studies by thorax computed tomography angio were negative. The purpose of this presentation is to validate the diagnostic input of nuclear medicine pulmonary perfusion in patients with new coronavirus infection with middle clinical pre-test for pulmonary embolism disease whose scanographic images by thorax computated tomography angio ruled out thrombosis.


REFERENCES

  1. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus disease 2019-COVID-19. Clin Microbiol Rev. 2020;33(4):e00028-20. doi: 10.1128/CMR.00028-20.

  2. Satarker S, Nampoothiri M. Structural proteins in Severe Acute Respiratory Syndrome Coronavirus-2. Arch Med Res. 2020;51(6):482-491. doi: 10.1016/j.arcmed.2020.05.012.

  3. Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, de Lima M, Nascimento DC, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217(12):e20201129. doi: 10.1084/jem.20201129.

  4. Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, et al. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med. 2020;217(6):e20200652. doi: 10.1084/jem.20200652.

  5. Morris G, Bortolasci CC, Puri BK, Olive L, Marx W, O'Neil A, et al. The pathophysiology of SARS-CoV-2: a suggested model and therapeutic approach. Life Sci. 2020;258:118166. doi: 10.1016/j.lfs.2020.118166.

  6. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762-768. doi: 10.1093/cid/ciaa248.

  7. Palmer OMP, Carter M, Chang CH, Lucko N, Jackson VM, Sun Q, et al. Effects of transport temperature on the stability of inflammatory, hemostasis, endothelial function, and oxidative stress plasma biomarker concentrations. Shock. 2017;47(6):715-719. doi: 10.1097/SHK.0000000000000805.

  8. Yu B, Li X, Chen J, Ouyang M, Zhang H, Zhao X, et al. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. J Thromb Thrombolysis. 2020;50(3):548-557. doi: 10.1007/s11239-020-02171-y.

  9. Watanabe N, Fettich J, Kücük NO, Kraft O, Mut F, et al. Modified PISAPED criteria in combination with ventilation scintigraphic finding for predicting acute pulmonary embolism. World J Nucl Med. 2015;14(3):178-183. doi: 10.4103/1450-1147.163248.




Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Table 1

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Crit. 2025;39